Home » Topics » Regulatory » Patents

Patents
RSS

Merck describes improved chemotherapeutic agents

Feb. 7, 1997

Peptide derivatives with antiinflammatory properties described by U.S. researchers

Feb. 7, 1997

Tsumura describes agents for dermatitis

Feb. 7, 1997

Chymase inhibitors from Green Cross

Feb. 7, 1997

BASF discloses antithrombotic from ticks

Feb. 6, 1997

BTG describes immunosuppressive antibodies

Feb. 6, 1997

Egis develops 5-LO inhibitors

Feb. 6, 1997

Antitumor prodrugs for ADEPT from Pharmachemie

Feb. 6, 1997

Tanabe Seiyaku discloses novel antinephritic compounds

Feb. 6, 1997

Magainin analogues reported by Scripps

Feb. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...